Next Article in Journal
Phytochemical Composition of the Fruit of Large Cranberry (Vaccinium macrocarpon Aiton) Cultivars Grown in the Collection of the National Botanic Garden of Latvia
Next Article in Special Issue
GC-MS Analysis of Bioactive Compounds Extracted from Plant Rhazya stricta Using Various Solvents
Previous Article in Journal
Modification of Sugar Profile and Ripening in Atemoya (Annona × atemoya Mabb.) Fruits through Copper Hydroxide Application
Previous Article in Special Issue
Botanical Antcin K Alleviates High-Fat Damage in Palm Acid Oil-Treated Vascular Endothelial Cells and Macrophages
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Cytotoxic Potential of Diospyros villosa Leaves and Stem Bark Extracts and Their Silver Nanoparticles

by
Oluwatosin Temilade Adu
1,
Yougasphree Naidoo
1,
Johnson Lin
2,
Depika Dwarka
3,
John Mellem
3,
Hosakatte Niranjana Murthy
4 and
Yaser Hassan Dewir
5,*
1
Department of Biological Sciences, School of Life Sciences, College of Agriculture, Engineering and Science, University of KwaZulu-Natal, Westville Campus, Private Bag X54001, Durban 4000, South Africa
2
Department of Microbiology, School of Life Sciences, College of Agriculture, Engineering and Science, University of KwaZulu-Natal, Private Bag X54001, Durban 4000, South Africa
3
Department of Biotechnology and Food Technology, Durban University of Technology, P.O. Box 1334, Durban 4000, South Africa
4
Department of Horticultural Science, Chungbuk National University, Cheongju 28644, Republic of Korea
5
Plant Production Department, College of Food & Agriculture Sciences, King Saud University, Riyadh 11451, Saudi Arabia
*
Author to whom correspondence should be addressed.
Plants 2023, 12(4), 769; https://doi.org/10.3390/plants12040769
Submission received: 28 December 2022 / Revised: 3 February 2023 / Accepted: 6 February 2023 / Published: 8 February 2023
(This article belongs to the Special Issue Plant Therapeutics 2.0)

Abstract

:
Diospyros villosa is traditionally used for an anti-bacterial property. Its cytotoxic effects have not been studied before. Therefore, this study aimed to examine the nutritional properties as well the cytotoxic effects of D. villosa. The leaves and stem barks were subjected to three different extraction methods (methanol, chloroform and hexane) and their nanoparticles were synthesized at two different temperatures (room temperature and at 80 °C). Thereafter, extracts were assessed using the associated AOCC protocols, for their nutritional content (moisture, fibre, proteins, lipid, ash and hydrolysable carbohydrates). Diospyros villosa extracts and their corresponding nanoparticles were then incubated overnight with cancerous and noncancerous cell lines to evaluate their cytotoxic potential. The nutritional analysis revealed that both young and mature leaves were rich sources of protein having values of 14.95% and 11.37% respectively. The moisture content was observed to be higher in all the leaf types (8.54 ± 0.75%, 9.67 ± 0.98% and 7.40 ± 0.80%) compared to the stem (2.13 ± 0.07%) respectively. The MTT cytotoxicity assay showed that the cell viability of MCF-7 cell lines was significantly lower when exposed to hexane and chloroform leaves extracts of D. villosa (IC50 of 26.64 and 26.07 µg mL−1) respectively, compared to camptothecin (36.54 µg mL−1). Similarly, the MCF-7 cell viability was observed to be significantly lower when exposed to hexane and chloroform stem extracts of D. villosa (IC50 of 24.57 and 3.92 µg mL−1), compared to camptothecin (36.54 µg mL−1). The cell viability of A549 cell lines was also found lower when exposed to the hexane and chloroform extracts (IC50 of 7.76 and 4.59 µg mL−1) compared to camptothecin (IC50 of 19.26 µg mL−1). Furthermore, the viability of A549 cell lines was found lower when exposed to hexane and chloroform stem extracts of D. villosa (IC50 of 10.67 and 5.35 µg mL−1) compared to camptothecin (19.26 µg mL−1). The biosynthesized nanoparticles further displayed an anticancer activity with an IC50 value of 4.08 µg mL−1 when compared to the control (36.54 µg mL−1). However, the HEK293 cell viability was observed to be significantly higher on exposure to hexane stem extracts of D. villosa (IC50 of 158.5 µg mL−1) compared to camptothecin (IC50 of 14.77 µg mL−1). Therefore, Diospyros villosa leaves, stem bark and nanoparticles synthesized showed high potential for being considered as a candidate for an anti-cancer regimen.

1. Introduction

Cancer is a complex disease of uncontrolled growth of tumour cells due to signalling failure of oncogenic expressions resulting in many different types of cancers based on the origin of tumours in the particular organs [1]. An estimated 19.3 million new cancer cases and almost 10 million cancer deaths were reported in 2020 [2]. In fact, almost 11.7% of all the new cancer cases were reported to be female breast cancer and identified to be the most commonly diagnosed cancer in women [3]. Up to now, efforts are made to develop efficient approaches not only to diagnose cancer but also to treat the disease. A variety of therapeutic approaches including chemotherapy [4], molecularly targeted therapy [5], gene therapy [6], radiotherapy [7], immunotherapy [8] phototherapy [9], and embolotherapy [10] have been extensively applied to treat cancers in clinic. All these therapeutic measures present severe effects on the patients. However, there is still a need to secure a more reliable, cheaper and readily available therapeutic measure, with limited side effects.
There are many medicinal plants with therapeutic properties that have been used traditionally in many countries and are also being researched by various groups in the form of extracts against different types of cancer for possible treatments [11,12,13]. Additionally, dietary supplementation of phytonutrients is an emerging trend that provides a multifaceted defensive mode against various maladies such as cancer by limiting tumour development by binding to the cancer cell membrane or their receptors, thereby initiating cytotoxicity and apoptosis inhibiting tumour growth [14]. These phytonutrients possess certain key advantages over alternative chemotherapy agents such as their affinity and level of tissue penetration, strong target specificity and low toxicity [15] Medicinal plant therapeutic agents also contribute indirectly by activating the endogenous defence systems by modulating cellular signalling processes [16] and thereby enhancing the overall health status. There is an abundance of medicinal shrubs, vegetables and trees in South Africa that are yet to be prodded meticulously for their health-promoting properties. Similarly, nanoparticles synthesized from green plants were reported to possess unique biological properties and hence become useful in therapeutics and drug delivery [17]. The biosynthesized nanoparticles eradicate cancer cells by flow and penetration to different regions of tumours through blood vessels into the target cells [18].
Diospyros villosa (L.) De Winter (D. villosa) is an African plant which naturally occurs in southern parts of the continent. D. villosa root was reported to be used by a group of herbalists found in the botanically diverse Western Cape of South Africa to treat gastrointestinal complaints, worms, and flatulence [19]. Also, the root of the D. villosa plant was used in the rural community of northern Maputaland to treat pain and dysmenorrhea [20]. Diospyros ferrea (Wild.) leaves nanoparticles were reported for their anti-cancer activities against MCF-7 cancer cell lines [21]. Hence, this research study was then geared towards making a significant contribution to the present search being carried out to ascertain the nutritive contents of D. villosa leaves and stem bark and to investigate the anti-cancer properties of D. villosa leaves and stem bark as well as its nanoparticles on breast cancer cell lines (MCF-7), human embryonic kidney immortalized cell lines (HEK 293), and adenocarcinomic human alveolar basal epithelial cancer cells (A549).

2. Results

The yield of different extracts of D. villosa leaves and stem bark is given in Table 1. It was observed that methanol extraction in the leaves produced a maximum yield of 10.8%, whereas chloroform and hexane extraction in the leaves yielded 8.4% and 7.1% respectively. Similarly, the methanol extraction in the stem bark produced a yield of 7.2% meanwhile, chloroform and hexane extraction yielded 7.9% and 10.3% respectively. The yield obtained from leaves nanoparticles at room temperature and 80 °C was observed to be 7.4% and 5.5% respectively. Also, the percentage yield from stem nanoparticles at room temperature and 80 °C was found to be 4.0% and 3.95% respectively.
The proximate analysis of different extracts of D. villosa leaves and stem bark is given in Table 2. It was observed that the protein content of mature leaves of D. villosa was found significantly (p < 0.05) higher compared to the stem F(3, 11) = 51.45, p = 0.0009. Similarly, the moisture content of the leaves (emergent, young and adult) was found significantly (p < 0.05) higher compared to the stem. Also, the moisture content in the leaves was found significantly higher compared to the stem bark. Meanwhile, the moisture content was not as much as the reported value (14.83%) in the leaves of Diospyros mespiliformis-a member of the same family (Ebenaceae) by Ebbo et al. [22]. The protein content in the mature leaves (14.95%) was slightly higher than the reported values (11.49%) [22]. Furthermore, the crude fibre content in the leaves and stem bark was higher compared to the reported value in Diospyros mespiliformis leaves.
The MTT assay was used to determine the cytotoxicity of the D. villosa leaves and stem using different extraction media as well as the biosynthesized AgNPs at different temperatures (RT and 80 °C) on cancerous and non-cancerous cell lines. For the extract to be anticancer, it should display toxicity on MCF-7, or A549 cancer cells and mild reactivity to HEK293 with further supporting evidence of IC50. The lower the IC50 values indicated, the higher the cytotoxic activity in cancerous cells.
Among the different leaf extracts, hexane extract showed a noteworthy cytotoxic effect on the MCF-7 cell line (IC50 26.64 µg mL−1) and chloroform extract showed a significant cytotoxic effect (IC50 26.07 µg mL−1) (Table 3 and Figure 1). However, the methanolic leaf extract showed the best cytotoxic effect (IC50 7.09 µg mL−1) in MCF-7 cells. The hexane, chloroform and methanol leaf extract demonstrated greater anti-cancer activity than the standard camptothecin (IC50 36.54 µg mL−1).
The cytotoxicity of MCF-7 cells by both hexane (IC50 24.57 µg mL−1) and chloroform stem extracts (IC50 3.919 µg mL−1) (Table 4 and Figure 2) was much greater compared to camptothecin (IC50 value of 36.54 µg mL−1). However, the greatest anticancer activity produced in MCF-7 cells was demonstrated by the methanolic stem extract (IC50 0.17 µg mL−1).
The Diospyros villosa stem nanoparticles biosynthesized at RT showed a significant toxic effect on MCF-7 (4.08 µg mL−1) compared to Camptothecin (36.54 µg mL−1) (Table 5 and Figure 3). In addition, the leaves nanoparticle synthesized at RT showed a significant toxic effect on MCF-7 cell lines (IC50 2.03 µg mL−1) The IC50 of the leaves and stem nanoparticles synthesized at 80 °C was found to be 2.53 and 5.11 µg mL−1 respectively.
The viability of the HEK 293 cell line was observed to be higher on exposure to methanolic leaves extract of D. villosa (IC50 41.85 µg mL−1), chloroform leaves extract (IC50 of 198.5 µg mL−1) and hexane leaf extract (IC50 of 158.5 µg mL−1) compared to camptothecin (IC50 of 14.77 µg mL−1) (Table 6 and Figure 4).
The viability of HEK293 cells was further observed to be greater when exposed to hexane stem extract of D. villosa (IC50 of 45.13 µg mL−1) (Figure 5). However, the viability of the HEK293 cells was largely affected when treated with the chloroform (IC50 of 3.93 µg mL−1) and methanolic (IC50 of 0.10 µg mL−1) extracts of D. villosa (Figure 5). Camptothecin produced an IC50 of 14.77 µg mL−1 (Table 7).
Diospyros villosa leaves nanoparticles biosynthesized at RT showed a significant toxic effect on the HEK293 cell line (IC50 of 4.77 and 7.09 µg mL−1) compared to camptothecin (14.77 µg mL−1) (Table 8 and Figure 6). The viability of HEK293 cells was higher when exposed to leaves and stem nanoparticles (IC50 of 333.8 and 51.36 µg mL−1) of D. villosa (synthesized at 80 °C).
The cell viability of A549 cells on exposure to chloroform (IC50 of 4.592 µg mL−1) and hexane leaves extract (IC50 of 7.76 µg mL−1) showed a greater anti-cancer effect compared to camptothecin (IC50 of 19.26 µg mL−1) (Table 9 and Figure 7).
In addition, the cell viability of A549 cells was observed to be lower on exposure to hexane stem extract (with IC50 value of 5.35 µg mL−1), chloroform stem extract (IC50 of 10.67 µg mL−1) and methanolic extract (13.48 µg mL−1) of D. villosa compared to control (IC50 of 19.26 µg mL−1) (Table 10 and Figure 8).
The viability of A549 cells was observed to be lower on exposure to D. villosa stem nanoparticles at 80 °C and RT (IC50 values of 5.03 and 4.93 µg mL−1 respectively) compared to control (19.26 µg mL−1) (Table 11 and Figure 9).

3. Discussion

It was observed that the methanol extract produced maximum extraction yield. This is in line with Abdullah et al. [23] who reported previously that methanol extract of different plants usually yields significantly higher amounts compared to chloroform and hexane extract of same plants and it was further explained that it may be owing to occurrence of functional particles which are mostly polar organic phytochemical and are always available in most medicinal plants. For most studies, crude fibre, protein and good energy are considered as the main determinants of food types, and very few studies are available on the elemental composition of the Diospyros edible species. Crude fibre and protein in Diospyros leaves are well within the range as reported by earlier workers for other wild edibles [24,25]. The relatively high fibre content is an indication that the intake of D. villosa leaves could enhance peristalsis along gastrointestinal tract, digestion and even prevent constipation [26]. High fibre intake could lead to a reduced incidence of cohorts of metabolic syndrome disorder [27]. Dietary proteins are pivotal in the manufacturing and safeguarding of certain organic materials necessary for smooth functioning of human body [25]. The relatively high protein content of D. villosa could make it a useful supplement to diets with few proteins. Considering these nutritional values of D. villosa, the leaves seem to be fit for human consumption. However, there is still need for further identification and assessment of the protein make-up in the leaves and perhaps, the other vital and essential nutritive components of the plant.
Diospyros villosa leaves have long been recognized as a traditional medicinal plant. However, the putative anti-cancer effects of D. villosa leaves and their mechanisms of action have not been scientifically evaluated previously. As illustrated in Figure 1 and Figure 7, viability assays revealed that MCF-7 and A549 cells were more vulnerable to the plant extracts of D. villosa leaves than HEK293 cells. Similarly, a same trend was observed with D. villosa stem bark (Figure 2 and Figure 8). MCF-7 and A549 cells were more vulnerable to stem extracts of D. villosa. Thumbrain et al. [28] pinpointed that if an extract should be an anticancer agent, it should display toxicity on the A549 and MCF-7 cell lines while being somewhat less toxic to HEK293 cells. In this study, both leaves and stem bark exhibited strong cytotoxicity against MCF-7 and A549 cells but with disproportionate trend towards HEK293 cells. This shows that D. villosa extracts may not be toxic to normal cells, which makes it an ideal anticancer agent.
The exact mechanism of action through which the plant extracts exhibited its toxicity on cells was not established in this study. Earlier studies further demonstrated that most proteins in typical African diet come from high quality plant protein [29]. Elevated levels of protein and essential amino acids can inhibit the cancer progression and growth. This is in agreement with Gao et al. [30] who reported that plant proteins activated IGF-1 insulin signalling in order to regulate cancer growth and autophagy but to a very little extent. In addition, the presence of considerable amount of protein in the plant may be considered an avenue for building a complex compound with them embedded functional phytochemicals, some of which are thought to stop carcinogenesis through their antioxidant properties by interfering with oxidative stress signalling pathway and suppressing DNA damage. This is also in agreement with Kim et al. [31] where it was pointed out that a member of Diospyros genus (Diospyros kaki) exhibited cell death via activation of platelet-derived growth factor receptors (PDGFRs) which serve as the active binding site for membrane auto-phosphorylation. Our experimental findings support the notion that the incorporation of D. villosa protein into supplements may play a role in cancer inhibition and retrogression.
The results further showed that D. villosa leaves, stem and nanoparticles synthesized at room temperature were able to inhibit cell growth in vitro with high efficiency. Even more, the extracts showed more potency in MCF-7 cancer lines, displaying high cytotoxicity. This is in line with Park et al. [32] where Diospyros kaki (Thumb.) suppressed the proliferation of human cancer cell lines by decreasing cyclin D1 expression. Although, the mechanism of D. villosa cancer inhibition may not have been achieved through cyclin D1 expression, the excellent display of IC50 may be considered. In this present study, the D. villosa leaves, stem and biosynthesized nanoparticles with the highest anticancer activity presented IC50 showing potent inhibitory effect on the growth of MCF-7 and A549 cell lines. The results showed that the D. villosa plant presented the lower range of IC50 compared to a referenced anticancer medication, showing the higher potency. On the other hand, the methanolic extract of D. villosa plant showed the lowest potency in inhibiting cell growth in MCF-7 and A549 cells. Taking in account that the beneficial properties of Diospyros plants are related to a variety of bioactive components that enhance antioxidant capacity and consequently anticancer activity [33,34]. Diospyros villosa may be strong candidates for future cancer studies, having high antioxidant and anticancer activity. The activities of both hexane leaves and stem extracts were quite promising as effective anticancer agents. The hexane stem extract did not just only inhibit the growth of MCF-7 cells but also possess a lower IC50 compared to standard. The lowest value of IC50 as produced by methanolic leaves extracts would have been considered the best, but higher percentage viability of MCF-7 cells further explained that the methanolic leaves extract may rather be considered a strong antioxidant/antibacterial than anticancer agent. Also, the hexane stem extract displayed both lower IC50 value compared to the standard and a low percentage viability of A549 cells. In fact, the less toxicity of hexane leaves extract to HEK293 was observed as the IC50 values was quite higher. Both hexane stem extract and the synthesized stem nanoparticles at room temperature showed marked anticancer activities.

4. Materials and Methods

4.1. Plant Collection

Fresh samples of mature leaves and stem bark of D. villosa were collected from KwaZulu-Natal, Durban, South Africa (29°84′33.6″ S, 31°4′12″ E). The plant was identified and a voucher specimen was deposited in the Ward Herbarium (01/18257) at the School of Life Sciences, University of KwaZulu-Natal, Westville campus. The collected plant parts (leaves and stem bark) were washed, air-dried and pulverized into fine powder. The powdered samples were kept in a cool dry place for extraction purposes.

4.2. Plant Extraction

Powdered samples of the plant weighing 8 g were heated to a temperature of 40 °C for 15 min with 100 mL of 95% methanol in a round bottom flask attached to a Soxhlet apparatus. The crude extract was retained and the process was repeated thrice. Successive extractions using chloroform and hexane, respectively, were carried out after 30 min intervals. The condensate was further evaporated to dryness under reduced pressure at 40 °C in a rotary evaporator. The crude extract was stored at 4 °C and used within 48 h for further tests.
The   extraction   yield   ( % ) = Weight   of   the   dry   extract   g Weight   of   the   sample   used   for   the   extraction   g   ×   100 .

4.3. Proximate Analysis

The proximate analysis of leaves and stem samples including the moisture, crude fibre, proteins, lipids, ash content and hydrolysable carbohydrates were assessed. Moisture content was determined by drying the leaves and stem samples at 80 °C in an oven until a constant weight was obtained [35]. The crude fibre was determined by the loss in weight on ignition of dried residue following the digestion of fat-free samples with 1.25% each of sulphuric acid and sodium hydroxide solutions [35]. The total protein content (N × 6.25) was estimated by the macro-Kjeldahl nitrogen assay method using a digestion apparatus combined with the photo-colourimetric method described by Baethgen and Alley [36]. The total lipids content was determined according to AOAC [37], by n-hexane extraction using an automatic Soxhlet analyzer (Soxtherm 2000 Automatic, C. Gerhardt, Northants, UK).

4.4. Synthesis of Silver Nanoparticles (AgNPs)

Silver nitrate (1 M AgNO3; Sigma Aldrich, South Africa) was prepared by dissolving 0.17 g in 100 mL of distilled water. Following this, 1 mM of AgNO3 was prepared by diluting 10 mL in distilled water (90 mL). The reduction of Ag+ was achieved by adding 5 mL of each D. villosa aqueous extract (leaves or stem bark) to 20 mL of 1 mM AgNO3. The mixtures were incubated for 24 h in the light at room temperature (RT; 24 °C). The procedure was repeated with the incubation at 80 °C by heating the extracts in a water bath for 60 min. The colour change from light yellow to dark brown was indicative of the presence of AgNPs [38,39]. Syntheses were performed in triplicate.

4.5. Quantification of AgNPs

Each AgNP solution was subjected to centrifugation using an Eppendorf microcentrifuge (5804/5804R, Sigma-Aldrich, Inc., St. Louis, MO, USA). The treatment solutions (leaves and stem bark at room temperature and 80 °C) were separately transferred into pre-weighed microcentrifuge tubes and purified for 2 h at 1650× g and 4 °C. The supernatant from each solution was decanted and the insoluble residue was reconstituted in 20 mL sterile distilled water and centrifuged repeatedly three more times for effective removal of unreacted materials. Samples were then oven-dried at 40 °C for 24 h after which the tubes were re-weighed to obtain the yield of the synthesized AgNPs.

4.6. Measurement of Cell Viability

Human embryonic kidney (HEK293), breast cancer (MCF-7) and human lung cancer (A549) cells were donated by the Department of Biotechnology, Durban University of Technology. Cells were grown at 37 °C in a humidified incubator under 5% CO2 in Dulbecco’s modified Eagle’s medium (DMEM) containing 10% Foetal Bovine Serum (FBS) and antibiotics (Penicillin; 10,000 U mL−1 and Streptomycin sulphate; 10,000 U mL−1 [Penicillin/Streptomycin]). Antibiotics change the phenotype and morphology of cells; therefore, the use of the antibiotics should be in very low concentrations, thus for this study, 1% Penicillin/Streptomycin was used. The cells were grown until 80% confluence was reached with media replaced as necessary. After confluence was reached, cells were trypsinized and sub-cultured. The 3-(4,5 dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was used to determine the cytotoxicity of the extracts. The MTT assay was conducted according to Dwarka et al. [40] with minor modifications. Briefly, cells (50 μL of 1 × 102 cells mL−1), as well as 50 μL of DMEM, were seeded into a 96-well flat bottom plate and incubated (37 °C for 24 h) in a humidified incubator under 5% CO2. Cells were then treated with 50 μL of extracts at varying concentrations (7.8–1000 μg mL−1) prepared in 5% DMSO and incubated for 24 h. Camptothecin was used as a positive control. MTT reagent (20 μL, 5 mg mL−1) was added to the cells and incubated at 37 °C for 4 h. One hundred microliters of DMSO was then added to each well to solubilise the formazan salt formed, and absorbance was read at 570 nm on a microplate spectrophotometer (Multiscan Go, Thermo Scientific, Waltham, MA, USA) for both treated and untreated cells. The percentage viability was calculated using the following formula:
Cell   viability   ( % ) = Absorbance   of   treated   cells Absorbance   of   untreated   cells   ×   100

4.7. Statistical Analysis

Data are displayed as means ± SEM. Statistical analysis was performed using Graph Pad Prism 5 (Graph Pad Software Inc., San Diego, CA, USA). The results were compared using one-way ANOVA followed by Bonferroni post hoc tests. Also, two-way ANOVA followed by Bonferroni post hoc tests was used where necessary. Effects were considered statistically significant at p-value < 0.05. The lower the half maximal inhibitory concentration (IC50) of the cancerous cell lines, the more the potency of the extract as an anticancer agent.

5. Conclusions

In this work, we have explored the nutritive contents and anticancer effect of the D. villosa leaves and stem bark as well as the nanoparticles against three cancer cell lines. The study revealed that D. villosa had high fibre and protein contents. Diospyros villosa may therefore be considered a plant with great potential as food supplement. It is further possible to conclude that D. villosa extracts potentially inhibited the viability of human breast carcinoma and lung carcinoma cells. Hence, its incorporation into nutritive supplements may provide a prophylactic regimen to both breast and lung cancer.

Author Contributions

Conceptualization, O.T.A. and Y.N.; methodology, O.T.A., Y.N. and J.L.; formal analysis, O.T.A., Y.N., J.L., D.D. and J.M.; investigation, O.T.A., Y.N. and J.L.; formal analysis, O.T.A., Y.N., J.L., D.D. and J.M.; data curation, O.T.A., Y.N. and J.L.; formal analysis, O.T.A., Y.N., J.L., D.D. and J.M.; validation, H.N.M. and Y.H.D.; writing—original draft preparation, O.T.A., Y.N., J.L., D.D. and J.M.; writing—review and editing, O.T.A., Y.N., H.N.M. and Y.H.D.; visualization, H.N.M. and Y.H.D.; supervision, Y.N. All authors have read and agreed to the published version of the manuscript.

Funding

The authors acknowledge Researchers Supporting Project number (RSP2023R375), King Saud University, Riyadh, Saudi Arabia and TWAS-National Research Foundation (NRF), South Africa.

Data Availability Statement

All data are presented in the article.

Acknowledgments

The authors acknowledge Researchers Supporting Project number (RSP2023R375), King Saud University, Riyadh, Saudi Arabia. The authors are thankful to the TWAS-National Research Foundation (NRF) for their financial support and University of KwaZulu-Natal for providing research facilities for this work.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Anusewicz, D.; Orzechowska, M.; Bednarek, A.K. Lung squamous cell carcinoma and lung adenocarcinoma differential gene expression regulation through pathways of Notch, Hedgehog, Wnt, and ErbB signalling. Sci. Rep. 2020, 10, 1–15. [Google Scholar] [CrossRef]
  2. Sung, H.; Ferlay, J.; Siegel, R.L.; Laversanne, M.; Soerjomataram, I.; Jemal, A.; Bray, F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2021, 71, 209–249. [Google Scholar] [CrossRef] [PubMed]
  3. Bray, F.; Ferlay, J.; Soerjomataram, I.; Siegel, R.L.; Torre, L.A.; Jemal, A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2018, 68, 394–424. [Google Scholar] [CrossRef] [PubMed]
  4. Dickens, E.; Ahmed, S. Principles of cancer treatment by chemotherapy. Surgery 2018, 36, 134–138. [Google Scholar]
  5. Piawah, S.; Venook, A.P. Targeted therapy for colorectal cancer metastases: A review of current methods of molecularly targeted therapy and the use of tumor biomarkers in the treatment of metastatic colorectal cancer. Cancer 2019, 125, 4139–4147. [Google Scholar] [CrossRef] [PubMed]
  6. Carrillo, M.A.; Zhen, A.; Kitchen, S.G. The use of the humanized mouse model in gene therapy and immunotherapy for HIV and cancer. Front. Immunol. 2018, 9, 746. [Google Scholar] [CrossRef]
  7. Brundha, M.P.; Pathmashri, V.P.; Sundari, S. Quantitative changes of red blood cells in cancer patients under palliative radiotherapy-a retrospective study. Res. J. Pharm. Technol. 2019, 12, 687–692. [Google Scholar] [CrossRef]
  8. Dobosz, P.; Dzieciątkowski, T. The intriguing history of cancer immunotherapy. Front. Immunol. 2019, 10, 2965. [Google Scholar] [CrossRef]
  9. Chang, M.; Wang, M.; Wang, M.; Shu, M.; Ding, B.; Li, C.; Pang, M.; Cui, S.; Hou, Z.; Lin, J. A multifunctional Cascade bioreactor based on hollow-structured Cu2 MoS4 for synergetic cancer chemo-dynamic therapy/starvation therapy/phototherapy/immunotherapy with remarkably enhanced efficacy. Adv. Mater. 2019, 31, e1905271. [Google Scholar] [CrossRef]
  10. Kishore, S.A.; Bajwa, R.; Madoff, D.C. Embolotherapeutic strategies for hepatocellular carcinoma: 2020 update. Cancers 2020, 12, 791. [Google Scholar] [CrossRef]
  11. Kamble, S.S.; Gacche, R.N. Evaluation of anti-breast cancer, anti-angiogenic and antioxidant properties of selected medicinal plants. Eur. J. Integ. Med. 2019, 25, 13–19. [Google Scholar] [CrossRef]
  12. Goodarzi, S.; Tabatabaei, M.J.; Jafari, R.M.; Shemirani, F.; Tavakoli, S.; Mofassseri, M.; Tofighi, Z. Cuminum cyminum fruits as source of luteolin-7-O-glucoside, potent cytotoxic flavonoid against breast cancer cell lines. Nat. Prod. Res. 2018, 34, 1602–1606. [Google Scholar] [CrossRef] [PubMed]
  13. Aumeeruddy, M.Z.; Mahomoodally, M.F. Global documentation of traditionally used medicinal plants in cancer management: A systematic review. S. Afr. J. Bot 2021, 138, 424–494. [Google Scholar] [CrossRef]
  14. Chen, H.; Liu, R.H. Potential mechanisms of action of dietary phytochemicals for cancer prevention by targeting cellular signaling transduction pathways. J. Agric. Food Chem. 2018, 66, 3260–3276. [Google Scholar] [CrossRef] [PubMed]
  15. Soldati, L.; Renzo, L.D.; Jirillo, E.; Ascierto, P.A.; Marincola, F.M.; Lorenzo, A.D. The influence of diet on anti-cancer immune responsiveness. J. Transl. Med. 2018, 16, 75. [Google Scholar] [CrossRef]
  16. Marabini, L.; Melzi, G.; Lolli, F.; Dell’Agli, M.; Piazza, S.; Sangivanni, E.; Marinovich, M. Effects of Vitis vinifera L. leaves extract on UV radiation damage in human keratinocytes (HaCaT). J. Photochem. Photobiol. B 2020, 204, 111810. [Google Scholar] [CrossRef]
  17. Chenthamara, D.; Subramaiaam, S.; Ramakrishnan, S.G.; Krishnaswamy, S.; Essa, M.M.; Lin, F.H.; Qoronfleh, W. Therapeutic efficacy of nanoparticles and routes of administration. Biomat. Res. 2019, 23, 20. [Google Scholar] [CrossRef]
  18. Kang, Y.J.; Cutler, E.G.; Cho, H. Therapeutic nanoplatforms and delivery strategies for neurological disorders. Nano Converg. 2018, 5, 35. [Google Scholar] [CrossRef]
  19. Philander, L.A. An ethnobotany of Western Cape Rasta bush medicine. J. Enthnopharmacol. 2011, 138, 578–594. [Google Scholar] [CrossRef]
  20. de Wet, H.; Ngubane, S.C. Traditional herbal remedies used by women in a rural community in northern Maputaland (South Africa) for the treatment of gynaecology and obstetric complaints. S. Afr. J. Bot. 2014, 94, 129–139. [Google Scholar] [CrossRef]
  21. Rajesh, V.; Sophiya, J.; Packia, J.S.J.; Arumugam, P.; Jayaraman, P. Biosynthesis of silver nanoparticles using Diospyros ferrea (Willd.) bakh. leaves and evaluation of its antioxidant, anti-inflammatory, antimicrobial and anticancer activity. J. Bionanoscience 2017, 11, 24–33. [Google Scholar] [CrossRef]
  22. Ebbo, A.A.; Sani, D.; Suleman, M.M.; Ahmed, A.; Hassan, A.Z. Phytochemical composition, proximate analysis and antimicrobial screening of methanolic extract of Diospyros mespiliformis Hochst ex a. Dc (Ebenaceae). Pharmacogn. J. 2019, 11, 362–368. [Google Scholar] [CrossRef]
  23. Abdullah, S.; Jan, S.E.; Kwak, M.K.; Chong, K.P. Ganoderma boninense mycelia for phytochemicals and secondary metabolites with antibacterial activity. J. Microbiol. 2020, 58, 1054–1064. [Google Scholar] [CrossRef]
  24. Tuncturk, M.; Eryigit, T.; Sekeroglu, N.; Ozgokee, F. Chemical composition of some edible wild plants grown in Eastern Anatolia. AJEONP 2015, 2, 31–34. [Google Scholar]
  25. Unuofin, J.O.; Otunola, G.A.; Afolayan, A.J. Nutritional evaluation of Kedrostis africana (L.) Cogn: An edible wild plant of South Africa. Asian Pac. J. Trop. Med. 2017, 7, 443–449. [Google Scholar] [CrossRef]
  26. Nyamwamu, N.C.; Okari, O.J.; Gisesa, W.N.O. A survey of medicinal plants used by the gusii community in the treatment of digestive disorders and other inflammatory conditions. J. Med. Plants 2020, 8, 21–33. [Google Scholar]
  27. Kim, H.; Lee, K.; Rebholz, C.M.; Kim, J. Plant-based diets and incident metabolic syndrome: Results from a South Korean prospective cohort study. PLoS Med. 2020, 17, e1003371. [Google Scholar] [CrossRef]
  28. Thumbrain, D.; Dwarka, D.; Gerrano, A.S.; Mellem, J.J. Antioxidant and apoptotic potential of protein isolates derived from Vigna unguiculata (L.) Walp. Int. J. Food Sci. 2020, 55, 2813–2823. [Google Scholar]
  29. Sterling, S.R.; Bowen, S.A. The potential for plant-based diets to promote health among blacks living in the United States. Nutrients 2019, 11, 2915. [Google Scholar] [CrossRef]
  30. Gao, X.; LaValley, M.P.; Tucker, K.L. Prospective studies of dairy product and calcium intakes and prostate cancer risk: A meta-analysis. J. Natl. Cancer Inst. 2005, 97, 1768–1777. [Google Scholar] [CrossRef]
  31. Kim, H.S.; Suh, J.S.; Jang, Y.K.; Ahn, S.H.; Raja, G.; Kim, J.C.; Jung, Y.; Jung, S.H.; Kim, T.J. Anti-cancer potential of persimmon (Diospyros kaki) leaves via the PDGFR-Rac-JNK pathway. Sci. Rep. 2020, 10, 18119. [Google Scholar] [CrossRef]
  32. Park, S.B.; Park, G.H.; Song, H.M.; Son, H.J.; Um, Y.; Kim, H.Y.; Jeong, J.B. Anticancer activity of calyx of Diospyros kaki Thunb. through downregulation of cyclin D1 via inducing proteasomal degradation and transcriptional inhibition in human colorectal cancer cells. BMC Complement. Altern. Med. 2017, 17, 1–10. [Google Scholar] [CrossRef] [PubMed]
  33. Galo, Y.S.; Dauda, S.; Emmanuel, A. Phytochemical screening and antimicrobial activity of leaf and stem-bark aqueous extracts of Diospyros mespiliformis. Int. J. Biochem. Res. Rev. 2018, 22, 1–8. [Google Scholar]
  34. El-Hawary, S.S.; Tadros, S.H.; AbdelMohsen, M.M.; Mohamed, M.S.; Sheikh, E.E.; Nazif, N.M.; ElNasr, M.S. Phyto-and Bio-Chemical evaluation of Diospyros kaki L. cultivated in Egypt and its biological activities. Braz. J. Biol. 2020, 80, 295–304. [Google Scholar] [CrossRef]
  35. AOAC. Official Methods of Analysis of Association of Analytical Chemists, 17th ed.; Association of Official Agricultural Chemists International: Arlington, VA, USA, 2000. [Google Scholar]
  36. Baethgen, W.E.; Alley, M.W. A manual colorimetric procedure for measuring ammonium nitrogen in soil and plant kjeldahl digests. Commun. Soil Sci. Plant Anal. 1989, 20, 961–996. [Google Scholar] [CrossRef]
  37. AOAC. Official Methods of Analysis of the Association of Official Analytical Chemists, 15th ed.; Sec. 985.29.; The Association: Arlington, VA, USA, 1990; Volume II. [Google Scholar]
  38. Kannan, R.; Stirk, W.A.; Van Staden, J. Synthesis of silver nanoparticles using the seaweed Codium capitatum PC Silva (Chlorophyceae). S. Afr. J. Bot. 2013, 86, 1–4. [Google Scholar] [CrossRef]
  39. Sharma, S.; Kumar, S.; Bulchandani, B.D.; Taneja, S.; Banyal, S. Green synthesis of silver nanoparticles and their antimicrobial activity against Gram positive and Gram-negative bacteria. Int. J. Biotechnol. Bioeng. Res. 2013, 4, 711–714. [Google Scholar]
  40. Dwarka, D.; Thaver, V.; Naidu, M.; Koorbanally, N.A.; Baijanath, H. In vitro chemo-preventative activity of Strelitzia nicolai aril extract containing bilirubin. Afr. J. Tradit. Complement. Altern. Med. 2017, 14, 147–156. [Google Scholar] [CrossRef]
Figure 1. Cell viability of MCF-7 cancer cell line treated with different concentrations of D. villosa leaves. * (Camptothecin vs. CL); (Camptothecin vs. ML); p < 0.05. ** (Camptothecin vs. ML), p < 0.01.
Figure 1. Cell viability of MCF-7 cancer cell line treated with different concentrations of D. villosa leaves. * (Camptothecin vs. CL); (Camptothecin vs. ML); p < 0.05. ** (Camptothecin vs. ML), p < 0.01.
Plants 12 00769 g001
Figure 2. Cell viability of MCF-7 cancer cell lines treated with different concentrations of D. villosa stem extract. ** (Camptothecin vs. MSB), p < 0.01.
Figure 2. Cell viability of MCF-7 cancer cell lines treated with different concentrations of D. villosa stem extract. ** (Camptothecin vs. MSB), p < 0.01.
Plants 12 00769 g002
Figure 3. Cell viability of MCF-7 cancer cell lines treated with different concentrations of nanoparticles synthesized from D. villosa leaves and stem extract at room temperature and 80 °C. * (ML vs. Camptothecin), p < 0.05; *** (ML vs. Camptothecin), p < 0.001.
Figure 3. Cell viability of MCF-7 cancer cell lines treated with different concentrations of nanoparticles synthesized from D. villosa leaves and stem extract at room temperature and 80 °C. * (ML vs. Camptothecin), p < 0.05; *** (ML vs. Camptothecin), p < 0.001.
Plants 12 00769 g003
Figure 4. Cell viability of HEK293 cancer cell lines treated with different concentrations of D. villosa leaves extract. * (ML vs. Camptothecin); * (CL vs. camptothecin), p < 0.05.
Figure 4. Cell viability of HEK293 cancer cell lines treated with different concentrations of D. villosa leaves extract. * (ML vs. Camptothecin); * (CL vs. camptothecin), p < 0.05.
Plants 12 00769 g004
Figure 5. Cell viability of HEK293 cancer cell lines treated with different concentrations of D. villosa stem extract.
Figure 5. Cell viability of HEK293 cancer cell lines treated with different concentrations of D. villosa stem extract.
Plants 12 00769 g005
Figure 6. Cell viability of HEK 293 cancer cell lines treated with different concentrations of nanoparticles synthesized from D. villosa leaves and stem extract at room temperature and 80 °C. * (Leaves RT vs. Camptothecin); p < 0.05. *** (Leaves RT vs. Camptothecin), p < 0.001; *** (Leaves 80 °C vs. Camptothecin), p < 0.001.
Figure 6. Cell viability of HEK 293 cancer cell lines treated with different concentrations of nanoparticles synthesized from D. villosa leaves and stem extract at room temperature and 80 °C. * (Leaves RT vs. Camptothecin); p < 0.05. *** (Leaves RT vs. Camptothecin), p < 0.001; *** (Leaves 80 °C vs. Camptothecin), p < 0.001.
Plants 12 00769 g006
Figure 7. Cell viability of A549 cancer cell lines treated with different concentrations of D. villosa leaves extract. *** (ML vs. Camptothecin), p < 0.001.
Figure 7. Cell viability of A549 cancer cell lines treated with different concentrations of D. villosa leaves extract. *** (ML vs. Camptothecin), p < 0.001.
Plants 12 00769 g007
Figure 8. Cell viability of A549 cancer cell lines treated with different concentrations of D. villosa stem extract. *** (MSB vs. Camptothecin), p < 0.001.
Figure 8. Cell viability of A549 cancer cell lines treated with different concentrations of D. villosa stem extract. *** (MSB vs. Camptothecin), p < 0.001.
Plants 12 00769 g008
Figure 9. Cell viability of A549 cancer cell lines treated with different concentrations of nanoparticles synthesized from D. villosa leaves and stem extract at room temperature and 80 °C. *** (Leaves RT vs. Camptothecin), p < 0.001. *** (Leaves 80 °C vs. Camptothecin), p < 0.001.
Figure 9. Cell viability of A549 cancer cell lines treated with different concentrations of nanoparticles synthesized from D. villosa leaves and stem extract at room temperature and 80 °C. *** (Leaves RT vs. Camptothecin), p < 0.001. *** (Leaves 80 °C vs. Camptothecin), p < 0.001.
Plants 12 00769 g009
Table 1. Yield of extracts of D. villosa leaves, stem bark and nanoparticles.
Table 1. Yield of extracts of D. villosa leaves, stem bark and nanoparticles.
Methanol (%)Chloroform (%)Hexane (%)Nanoparticle at RT (g/g of Dry Plant Material)Nanoparticle at 80 °C (g/g of Dry Plant Material)
Leaves10.88.47.10.070.055
Stem bark7.27.910.30.040.039
Table 2. Nutritional content (%) of investigated D. villosa leaves and stem bark.
Table 2. Nutritional content (%) of investigated D. villosa leaves and stem bark.
Literature
Emergent Leaves (%)Young Leaves (%)Mature Leaves (%)Stem (%)Leaves [22]Stem [22]
Protein8.50 ± 1.6111.37 ± 0.6814.95 ± 0.83 *5.22 ± 0.7211.49 ± 0.105.51 ± 0.10
Lipids11.97 ± 1.3611.39 ± 1.7714.37 ± 0.1613.34 ± 0.283.00 ± 0.011.83 ± 0.16
Crude fibre29.73 ± 2.71 *36.4 ± 3.49 *29.60 ± 2.77 *40.17 ± 3.63 *2.66 ± 0.166.83 ± 0.33
Ash8.33 ± 0.446.33 ± 0.606.67 ± 0.675.33 ± 0.6011.16 ± 0.4422.66 ± 0.33
Moisture8.54 ± 0.759.67 ± 0.987.40 ± 0.802.13 ± 0.0714.83 ± 0.4411.33 ± 0.60
Carbohydrate32.93 ± 0.6224.84 ± 0.9127.01 ± 0.4433.81 ± 0.3555.03 ± 0.0150.96 ± 0.25
Values are mean ± SD of carefully conducted triplicate experiments. * p < 0.05.
Table 3. IC50 values of methanol, chloroform and hexane extract of D. villosa leaf against MCF-7 cell.
Table 3. IC50 values of methanol, chloroform and hexane extract of D. villosa leaf against MCF-7 cell.
Methanol Leaf Extr.Chloroform Leaf Extr.Hexane Leaf Extr.Camptothecin
IC500.1626.0726.6436.54
Table 4. IC50 values of methanol, chloroform and hexane extract of D. villosa stem against MCF-7 cell.
Table 4. IC50 values of methanol, chloroform and hexane extract of D. villosa stem against MCF-7 cell.
Methanol Leaf Extr.Chloroform Leaf Extr.Hexane Leaf Extr.Camptothecin
IC500.1626.0726.6436.54
Table 5. IC50 values of D. villosa leaves and stem bark nanoparticles at both RT and 80 °C against MCF-7 cell.
Table 5. IC50 values of D. villosa leaves and stem bark nanoparticles at both RT and 80 °C against MCF-7 cell.
Leaves (RT)Stem (RT)Leaves (80 °C)Stem (80 °C)Camptothecin
IC502.034.082.535.1136.54
Table 6. IC50 values of methanol, chloroform and hexane extract of D. villosa leaf against HEK293 cell.
Table 6. IC50 values of methanol, chloroform and hexane extract of D. villosa leaf against HEK293 cell.
Methanol Leaf Extr.Chloroform Leaf Extr.Hexane Leaf Extr.Camptothecin
IC50158.5198.541.8514.77
Table 7. IC50 values of methanol, chloroform and hexane extract of D. villosa stem against HEK293 cell.
Table 7. IC50 values of methanol, chloroform and hexane extract of D. villosa stem against HEK293 cell.
Meth. Stem Extr.Chloroform Stem Extr.Hexane Stem Extr.Camptothecin
IC5045.13.930.1014.77
Table 8. IC50 values of D. villosa leaves and stem bark nanoparticles at both RT and 80 °C against HEK293 cell.
Table 8. IC50 values of D. villosa leaves and stem bark nanoparticles at both RT and 80 °C against HEK293 cell.
Leaves (RT)Stem (RT)Leaves (80 °C)Stem (80 °C)Camptothecin
IC504.777.09333.8051.3614.77
Table 9. IC50 values of methanol, chloroform and hexane extract of D. villosa leaf against A549 cell.
Table 9. IC50 values of methanol, chloroform and hexane extract of D. villosa leaf against A549 cell.
Methanol Leaf Extr.Chloroform Leaf Extr.Hexane Leaf Extr.Camptothecin
IC507.764.597.0919.26
Table 10. IC50 values of methanol, chloroform and hexane extract of D. villosa stem against A549 ceFll.
Table 10. IC50 values of methanol, chloroform and hexane extract of D. villosa stem against A549 ceFll.
Meth. Stem Extr.Chloroform Stem Extr.Hexane Stem Extr.Camptothecin
IC5010.675.3513.4819.26
Table 11. IC50 values of D. villosa leaves and stem bark nanoparticles at both RT and 80 °C against A549 cell.
Table 11. IC50 values of D. villosa leaves and stem bark nanoparticles at both RT and 80 °C against A549 cell.
Leaves (RT)Stem (RT)Leaves (80 °C)Stem (80 °C)Camptothecin
IC507.134.9333.805.0319.26
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Adu, O.T.; Naidoo, Y.; Lin, J.; Dwarka, D.; Mellem, J.; Murthy, H.N.; Dewir, Y.H. Cytotoxic Potential of Diospyros villosa Leaves and Stem Bark Extracts and Their Silver Nanoparticles. Plants 2023, 12, 769. https://doi.org/10.3390/plants12040769

AMA Style

Adu OT, Naidoo Y, Lin J, Dwarka D, Mellem J, Murthy HN, Dewir YH. Cytotoxic Potential of Diospyros villosa Leaves and Stem Bark Extracts and Their Silver Nanoparticles. Plants. 2023; 12(4):769. https://doi.org/10.3390/plants12040769

Chicago/Turabian Style

Adu, Oluwatosin Temilade, Yougasphree Naidoo, Johnson Lin, Depika Dwarka, John Mellem, Hosakatte Niranjana Murthy, and Yaser Hassan Dewir. 2023. "Cytotoxic Potential of Diospyros villosa Leaves and Stem Bark Extracts and Their Silver Nanoparticles" Plants 12, no. 4: 769. https://doi.org/10.3390/plants12040769

APA Style

Adu, O. T., Naidoo, Y., Lin, J., Dwarka, D., Mellem, J., Murthy, H. N., & Dewir, Y. H. (2023). Cytotoxic Potential of Diospyros villosa Leaves and Stem Bark Extracts and Their Silver Nanoparticles. Plants, 12(4), 769. https://doi.org/10.3390/plants12040769

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop